Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cash and Short-Term Investments

Amneal Pharmaceuticals Inc Cash and Short-Term Investments Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cash and Short-Term Investments from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Cash and Short-Term Investments for the quarter ending December 12, 2018 was $213m a 77.40% increase of 165m year over year
  • Amneal Pharmaceuticals Inc Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $213m a 77.40% increase of 165m year over year
  • Amneal Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2018 was $213m a 64.38% increase of 137m from 2017
  • Amneal Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2017 was $76m a 58.27% increase of 44m from 2016
  • Amneal Pharmaceuticals Inc Annual Cash and Short-Term Investments for 2016 was $32m a -108.27% decrease of -34m from 2015
Other Balance Sheet Metrics:
  • Amneal Pharmaceuticals Inc Total Assets for the quarter ending December 12, 2018 was $4,353m a 68.78% increase of 2,994m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Equity for the quarter ending December 12, 2018 was $896m a 141.15% increase of 1,265m year over year
View Chart On Koyfin

Quarterly AMRX Cash and Short-Term Investments Data

12/2018$213m
09/2018$167m
06/2018$64m
03/2018$48m
12/2017$76m
09/2017$19m
03/2017$32m
12/2016$32m

Annual AMRX Cash and Short-Term Investments Data

2018$213m
2017$76m
2016$32m
2015$66m